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Background. Prior research indicates that heart failure (HF) patients exhibit signiﬁcant cognitive deﬁcits on neuropsychological
testing. Sleep apnea is associated with both HF and reduced cognitive function, but the combined impact of these conditions on
cognitive function is unknown. Methods. In the current study, 172 older adults with a dual diagnosis of HF and sleep apnea or HF
alone completed a battery of cognitive tests measuring attention, executive functioning, and memory. Results. Relative to patients
with HF alone, persons with both HF and sleep apnea performed worse on measures of attention after adjusting for demographic
and medical variables. Conclusions. The current ﬁndings suggest that HF patients with comorbid sleep apnea may be at greater
risk for cognitive impairment relative to HF patient without such history. Further work is needed to clarify mechanisms for these
ﬁndings and to determine whether the interactive eﬀects on cognitive function lead to poorer patient outcomes.
1.Introduction
The American Heart Association estimates that heart failure
(HF) aﬀects more than ﬁve million adults and costs an
estimated $30 billion annually in the United States alone
[1]. As the population of older adults and the frequency of
HF risk factors (e.g., hypertension and obesity) continue to
rise, it is estimated that one in ﬁve adults will develop HF
during their lifetime [1]. While the prevalence of this disease
is alarming, so are the consequences—HF is a leading cause
of hospitalization, morbidity, and mortality in the US [2–4].
HF is also a known risk factor for neurological disorders
including Alzheimer’s disease, stroke, and vascular dementia
[5–7]. However, it is now known that cognitive deﬁcits begin
to manifest long before patients are diagnosed with these
more serious conditions. For example, recent studies have
suggested that up to 75% of persons with HF exhibit
deﬁcits on testing, including reduced performance on tests
of memory, attention, executive function, and language [8–
11].
A growing number of contributors to cognitive impair-
ment in persons with HF have been identiﬁed, including
structural brain changes, reduced cerebral blood ﬂow, and
autonomicnervoussystemdisruption[12–16].Althoughnot
previously examined, it appears likely that sleep apnea is
another important contributor. Sleep apnea is common in
persons with HF and has an independent adverse impact
on cognitive function [17–21]. Recent work has shown
that persons with sleep apnea score poorly on measures of
attention [20–23], memory retrieval [24, 25], and executive2 Cardiovascular Psychiatry and Neurology
functioning [17, 19, 23, 26]. Consistent with these cognitive
deﬁcits, persons with sleep apnea also exhibit hippocampal
atrophy and decreased cerebral blood ﬂow [27, 28].
Despite these ﬁndings, no study has examined the pos-
sible additive eﬀects of sleep apnea on cognitive function in
persons with HF. Based on the independent eﬀects of sleep
apnea in past studies, we hypothesized that patients with
both disorders will demonstrate larger cognitive deﬁcits than
patients diagnosed only with HF.
2. Method
2.1. Participants. The local human subjects protection board
approved the study protocol, and all participants provided
written informed consent prior to participation.
Participantswereconsecutivelyenrolledinalongitudinal
study examining the neuropsychological aspects of HF. Strict
inclusion/exclusion criteria were chosen for entry into the
NIH-funded study to maximize generalizability to other
samples and to capture the independent contribution of HF
oncognitivefunction.Thus,participantsofthecurrentstudy
met all criteria for parent study entry. Researchers recruited
eligible participants from outpatient cardiology clinics.
Inclusion criteria included English-speaking participants
between 50 and 85 years of age with a documented history
of HF. Exclusion criteria included a history of neurological
disorder (e.g., stroke, Alzheimer’s Disease, and severe head
injury), history of signiﬁcant psychological problems (e.g.,
schizophrenia, bipolar disorder, and substance abuse), or
developmental disability (e.g., mental retardation).
2.2. Measures
2.2.1. Neuropsychological Test Battery. Participants com-
pleted a battery of well-established neuropsychological mea-
sures assessing multiple domains. Researchers examined
global cognitive functioning and cognitive performance in
the domains of memory, language, and attention/executive
function. An estimate of premorbid intelligence was also
calculated. Participants completed the following measures:
Global Cognitive Functioning
Modiﬁed Minimental Status Examination (3MS) [29]. This
test provides a screening measure of global cognitive
function. It is comprised of several short tasks, including
orientation, similarities, animal ﬂuency, learning as well as
brief and delayed recall of a short list of target words, and a
copy of a simple geometric ﬁgure.
Attention/Executive Function
Trail Making Test A and B [30]. In the Trail Making A
task, participants connect a series of 25 numbered dots in
ascending order as quickly as they can (e.g., 1-2-3, etc.).
Trail Making B adds a set-shifting component and requires
participants to alternate between numbers and letters in
ascending order (e.g., 1-A-2-B, etc.).
Frontal Assessment Battery [31]. This test employs several
short tasks to assess frontal system executive function. More
speciﬁcally, participants identify similarities among words
(e.g., automobile and boat), name as many words as they
can that start with a target letter (e.g., words that begin
with “M”), complete frontal-motor hand movements, and
using the dominant hand, tap patterns requiring cognitive
inhibition.
Letter Number Sequencing [32]. This test is a measure of
complex attention and working memory. Researchers read
strings of numbers and letters of increasing length, and
participants reorganize the numbers and letters according to
predetermined rules.
Stroop Test [33]. This test measures selective attention and
mental ﬂexibility. Participants ﬁrst read columns of words
spelling out colors printed in black ink (word subtest),
then identify the color of the ink in which a series of
X’s is printed (color subtest) and ﬁnally indicate the ink
color of a word (which spells out a color), ignoring the
verbal content (color-word subtest). Researchers calculated
an interference score based on word and color subtest
performances to determine expected performance on the
color-word subtest and compared the score to actual color-
word test performance.
Digit Symbol Coding [34]. This speeded task requires indi-
viduals to code numbers based on the corresponding sym-
bols. It is a valid and reliable measure of visuomotor speed
and complex attention.
Memory
California Verbal Learning Test-Second Edition (CVLT) [35].
Individuals learn, recall, and recognize a 16-item word list.
Speciﬁc variables include indices of learning (sum of trials
1–5), immediate recall, delayed recall, and recognition.
2.3. Cardiovascular Measures
Cardiovascular Fitness. Researchers assessed cardiovascular
endurance, used as a proxy for HF severity, with a 2-minute
step test [36]. Participants marched in place for two minutes,
bringing each knee up to a marked target on the wall set
individually at the midpoint between each participant’s hip
and knee. The number of times the right knee met this point
was counted.
2.4. Depressive Symptoms
Beck Depression Inventory II (BDI-II) [37]. Individuals com-
plete a 21-item self-report measure to evaluate the presence
and severity of depression. This measure has good psycho-
metric properties. Higher scores on the BDI-II indicate more
severe depressive symptoms.Cardiovascular Psychiatry and Neurology 3
Table 1: Demographic and clinical characteristics of 180 older adults with heart failure with and without sleep apnea.
Demographic Characteristics
HF patients HF patients
with SA without SA χ2(p) t(p)
(N = 42) (N = 138)
Age, mean (SD) 66.90 (8.43) 68.55 (11.00) — .89 (.37)
Female (%) 40.48 34.78 .45(.50) —
Education, mean (SD) 12.93 (2.10) 13.51 (3.13) — 1.39 (.17)
Clinical characteristics
Diabetes (%) 52.38 31.16 6.29 (.01) —
Hypertension (%) 88.10 64.50 8.54 (.003) —
2MST, mean (SD) 49.76 (23.75) 63.45 (23.22) — 3.33 (.001)
Note. 2MST: 2-minute step test.
2.5. Demographic and Medical History. History of sleep
apnea,alongwithothermedicalanddemographiccharacter-
istics, was collected through a review of participants’ medical
charts and self-report. Speciﬁcally, a medical record review
was conducted for all participants to corroborate self-report
and to ascertain a physician diagnosis of sleep apnea.
2.6. Analyses. All cognitive measures comprising each
domain were converted to standardized T or z scores
using published normative data. Multivariate analysis of
covariance (MANCOVA) was then performed with neu-
ropsychological measures of attention, executive function,
andmemoryasdependentvariables.Currentmedicalhistory
of sleep apnea (1 = positive history, 0 = negative history)
served as categorical independent variable in each analysis.
Demographic and medical covariates included education,
heart failure severity (as estimated by the two minute step
test),depressivesymptomatology(asassessedbytheBDI-II),
and history of type 2 diabetes and hypertension (1 = positive
history, 0 = negative history) were entered as covariates.
3. Results
3.1. Cognitive Impairment Is Prevalent in the Current Sample
of Older Adults with HF. The overall sample had an average
3MS score of 92.69 ± 5.49. Within the sample, 29.4% had
a 3MS score below 90, 34.5% between 90 and 95, and 36.1%
between95and100. HFpatientswithsleepapneaperformed
signiﬁcantlyworseonthe3MSthanHFpatientswithnosuch
history (t(178) = 7.57, P<. 05). Speciﬁcally, HF patients
withnohistoryofsleepapnea(N = 138)hadanaverage3MS
score of 93.32 ± 4.95, while HF patients with sleep apnea
(N = 42) averaged 90.62 ± 6.64 on the 3MS.
3.2. Demographic and Medical Diﬀerences between HF
Patients with and without Sleep Apnea. The original sample
consistedof180enrolledpersonswithHF.Asaresultofmiss-
ing data, 8 participants were excluded yielding a ﬁnal sample
size of 172 participants. The excluded participants did not
diﬀer in age (t(178) =− .391, P = .70), gender (χ2(1, N =
180) = .45, P = .50), education (t(178) = .99, P = .33),
2-minute step test (t(178) = .75, P = .45), the BDI-II
(t(178) =− .26, P = .80), history of diabetes (χ2(1, N =
180) = 2.53, P = .11), or history of hypertension (χ2(1,
N = 180) = 1.60, P = .21).
After exclusion of missing data, the current analyses
included 172 older adults (132 HF patients, M = 68.6y e a r s ,
35% female; 40 HF and sleep apnea patients, M = 67.1y e a r s ,
42.5% female). Sleep apnea was common in the current
samples of HF patients, with 23.3% having a history
according to medical records. Independent samples t-test
and chi square statistics were conducted to identify possible
diﬀerences between HF patients with and without sleep
apnea on important demographic and medical variables. No
signiﬁcant between-group diﬀerences were found for age,
gender, or education. However, HF patients with sleep
apnea performed signiﬁcantly worse on the two-minute
step test and were more likely to have hypertension and
diabetes. See Table 1 for complete demographic and clinical
characteristics.
3.3.SleepApneaandCognitiveFunctionintheCurrentSample
of Older Adults with HF. After adjusting for demographic
and medical variables, MANCOVA revealed signiﬁcant dif-
ferences between patients with and without sleep apnea on
measures of attention (Λ = .934, F(3,163) = 3.866, P =
.011). See Table 2. Speciﬁcally, posttests showed that persons
with sleep apnea had signiﬁcantly reduced performance on
Digit Symbol coding. HF patients with sleep apnea also
performed worse on Trail Making Test A and Letter Number
Sequencing, though diﬀerences were not signiﬁcant at P<
.05.
Although the omnibus test was not statistically signiﬁ-
cant for the eﬀects of sleep apnea on measures of executive
function (Λ = .970, F(3,163) = 1.653, P = .18), posttests
revealed that patients with sleep apnea performed signiﬁ-
cantly worse on the Frontal Assessment Battery (P = .03).
No between-group diﬀerences emerged on the memory tests
(Λ = .966, F(4,162) = 1.417, P = .23).
4. Discussion
In the present study, patients diagnosed with both HF and
sleep apnea exhibited poorer cognitive functioning than4 Cardiovascular Psychiatry and Neurology
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patients with HF alone, even after adjusting for key demo-
graphic and medical factors known to inﬂuence cognitive
function in this population. Speciﬁcally, patients with both
diagnoses demonstrated poorer attention test performance
than patients with HF alone. This pattern is consistent with
past literature, as both HF [8–11] and sleep apnea [17–
21] are independently associated with reduced cognitive
functioning. Several aspects of these ﬁndings warrant brief
discussion.
Patients with HF and sleep apnea scored signiﬁcantly
lower than those with HF alone on measures of attention,
including tests commonly used to measure attentional
deﬁcits in both populations [8–11, 21]. These ﬁndings are
consistent with both the HF [8–11] and sleep apnea [21]
literature that suggests that patients exhibit impairment on
attention tasks. These results are also consistent with both
thesleepapneaandHF-neuroimagingliterature.HFpatients
commonly exhibit reduced grey matter volume in regions
important for attention and executive functioning includ-
ing the frontal cortex, hippocampus, and cingulate [38].
Cerebral atrophy and infarcts [12, 16, 39]a sw e l la sw h i t e
matter hyperintensities [40, 41] are also common in this
population. While imaging research in sleep apnea is mixed,
studies have found signiﬁcant grey matter loss in the frontal
cortex, parietal cortex, temporal lobe, and cingulate as well
as atrophy in hippocampal regions [28]. Future imaging
research is needed to determine the possible interaction of
HF and sleep apnea on neuroimaging indices, as it may help
clarify the mechanisms by which these disorders adversely
impact the brain.
Clinically, these ﬁndings are important for both patient
populations. Previous work indicates that HF patients with
cognitive impairment are at elevated risk for mortality,
re-hospitalization, and reduced functional independence
[42–45]. The current ﬁndings suggest that persons with
both HF and sleep apnea may be at elevated risk for
such problems. Managing two diseases (e.g., medication
regimen, scheduling, and attending appointments, adhering
to physician instruction) requires more cognitive resources
than one. If these ﬁndings are replicated, HF patients
may beneﬁt from regular discussion of possible sleep
problems.
In contrast to the above, participants with both HF and
sleep apnea did not exhibit poorer memory performance
than those with HF alone. While memory dysfunction has
been frequently found in HF patients [8, 9], contradic-
tory ﬁndings exist in the sleep apnea literature. Short-
term verbal [19, 24, 25]a n dv i s u a l[ 18, 46]m e m o r y
impairments have been associated with sleep apnea in
some studies, but not others [47, 48]. Similarly, studies
examining procedural memory [24, 49] and long-term
semantic memory [18, 46]h a v eb e e ne q u i v o c a l[ 19, 23,
47]. It is also possible that the generally intact memory
performance of the current sample (typical performance
was within the average range) limits the statistical power of
these analyses. Longitudinal studies are needed to determine
whether memory function declines more rapidly in persons
with both HF and sleep apnea. Given the elevated risk
of Alzheimer’s disease in persons with HF [5], prospective
studies are needed to determine whether persons with both
HF and sleep apnea are at elevated risk for future memory
decline.
The current ﬁndings are limited in several ways. The cur-
rent study investigates persons with HF and sleep apnea or
HF alone but does not include a sleep apnea-only condition.
Due to this limitation, we were not able to directly compare
the cognitive eﬀects of HF, sleep apnea, and HF plus sleep
apnea in participants. Sleep apnea has been linked with
abnormalities on neuroimaging (i.e., hippocampal atrophy
and decreased cerebral blood ﬂow) and deﬁcits in cognitive
function independent of HF [17–21, 27, 28]. Thus, while
the current study suggests that comorbid sleep apnea is
associated with additive deﬁcits in cognitive function among
HF patients, it remains unclear whether the interaction
between sleep apnea and HF produces cognitive impairment
beyond the pathophysiological eﬀects of sleep apnea alone.
Comparing test performance in a demographically matched
group of patients with sleep apnea would provide a better
understandingofthecontributionofthisconditiontocogni-
tiveimpairmentsinpersonswithHFandallowresearchersto
determine if the eﬀect is additive or interactive. Additionally,
as noted above, prospective studies are needed to determine
whether the combination of HF and sleep apnea produce
diﬀerential patterns of cognitive decline. Past work shows
that each is associated with greater risk for Alzheimer’s
disease [5] though little is known about their possible
interaction.
Another limitation of the current analyses involves lim-
ited information about the severity of HF and sleep apnea.
Although we statistically controlled for acute HF severity in
the primary analyses, it is possible that persons with both
HF and sleep apnea diﬀer on important factors that were
unavailable to us, such as duration of HF and lower ejection
fraction,amongothers[50].Itseemsparticularlyworthwhile
for future studies to examine the contribution of depression
on cognitive function in these populations, as depression is
prevalent in both HF and sleep apnea populations [51–54]
and has been independently linked with cognitive impair-
ment [17–21]. Similarly, cognitive function in sleep apnea
populations has been suggested to decline as sleep apnea
severity increases [21]. The current study assessed diagnostic
history of sleep apnea and future studies should assess
sleep apnea severity using more objective measures of sleep
measures (i.e., polysomnogram sleep study) to elucidate
the additive eﬀects of sleep apnea on cognitive function in
persons with HF. Finally, participants did not complete a
sleep study as part of the current protocol, and categories
were based on examination of medical records and self-
report. Given the high prevalence rates, it is possible that
some participants had undetected sleep apnea, thus limiting
the observed ﬁndings. Future work is needed to clarify this
possibility.
In summary, the current ﬁndings indicate that patients
diagnosed with both HF and sleep apnea exhibit greater
cognitive dysfunction than patients with HF alone. Future
studies are needed to clarify the mechanisms for these
patterns, as well as their clinical implications.6 Cardiovascular Psychiatry and Neurology
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